Introducing OneBioSM Suite Accelerating timelines through integrated biologics development, manufacturing & supply Learn More Your one comprehensive BIOLOGICS partner Helping simplify your process and deliver better therapies to your patients faster Play Video Catalent Has Acquired Paragon Bioservices Combining Leaders in Gene Therapy & Complex Biologics Learn More Introducing OneBioSM Suite Reducing timelines, risk & complexity through integrated biologics development, manufacturing & supply Learn More Your one comprehensive BIOLOGICS partner Helping simplify your process and deliver better therapies to your patients faster Play Video Catalent Has Acquired Paragon Bioservices Combining Leaders in Gene Therapy & Complex Biologics Learn More How can we work together BiologicsDevelopment Drug SubstanceBiomanufacturing Drug ProductFill / Finish Clinical SupplyServices Latest News IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent’s Paragon Gene Therapy for Orphan Inherited Retinal Diseases WEBINAR: CONTINUOUS PROCESSING IN BIOMANUFACTURING There are many factors to consider when determining whether to adopt continuous processing. This webinar discusses a study comparing continuous and batch processing and challenges of adopting. Analytical Comprehensive integrated and standalone bioanalytical services for drug substance, drug product and intermediates, both new biologic entities and biosimilars/biobetters. Join Our Team Catalent is growing in Biologics and is making significant investments in people in this area. Explore global career opportunities with our Biologics team. Biologics Network Our network of biologics sites provides an integrated approach to get medicines to your patients faster anywhere in the world. See all of our locations NEWS IVERIC Bio Enters Into Strategic Manufacturing Relationship With Catalent’s Paragon Gene Therapy For Orphan Inherited Retinal Diseases Catalent to Launch OneBio Suite for Integrated Biologics Development, Manufacturing and Supply at BIO International 2019 Catalent Completes Acquisition of Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion EVENTS BioPharma Expo BPI Conference East 2019 PEGS Boston BIO International Convention EXPERT CONTENT Advances in Analytical Technology for Biopharmaceuticals Prefilled Syringes & Parental Manufacturing Accelerating Method Transfer: Effective Automation Of Biological Assays
